Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Precigen Q3 EPS $(1.06) Misses $(0.10) Estimate, Sales $2.922M Beat $500.000K Estimate

Author: Benzinga Newsdesk | November 13, 2025 04:12pm
Precigen (NASDAQ:PGEN) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.10) by 1015.79 percent. This is a 1077.78 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $2.922 million which beat the analyst consensus estimate of $500.000 thousand by 484.40 percent. This is a 206.61 percent increase over sales of $953.000 thousand the same period last year.

Posted In: PGEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist